| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| FHC97810A |
Anti-Human CCL2/MCP-1 Antibody (11k2) |
50 µg |
$285.00
|
 |
BUY
|
| FHC97810B |
Anti-Human CCL2/MCP-1 Antibody (11k2) |
100 µg |
$430.00
|
|
BUY
|
| RGK27501A |
Anti-SSEA-3/GalGb4 Antibody (2A9) |
100µg |
$475.00
|
|
BUY
|
| RGK27501B |
Anti-SSEA-3/GalGb4 Antibody (2A9) |
1mg |
$2,135.00
|
|
BUY
|
| DHC21901A |
Research Grade Abituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC21901B |
Research Grade Abituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC98804B |
Research Grade Abrilumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC98804A |
Research Grade Abrilumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17403B |
Research Grade Edrecolomab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17403A |
Research Grade Edrecolomab |
100 ug |
$380.00
|
|
BUY
|
| DHC29905B |
Research Grade Figitumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC29905A |
Research Grade Figitumumab |
100 ug |
$380.00
|
|
BUY
|
| DHB91703A |
Research Grade Fulranumab |
100 ug |
$430.00
|
|
BUY
|
| DHB91703B |
Research Grade Fulranumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHB95602A |
Research Grade Gevokizumab |
100 ug |
$420.00
|
|
BUY
|
| DHB95602B |
Research Grade Gevokizumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHE43201B |
Research Grade Ivuxolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE43201A |
Research Grade Ivuxolimab |
100 ug |
$380.00
|
|
BUY
|
| DHB10201A |
Research Grade Prezalumab |
100 ug |
$380.00
|
|
BUY
|
| DHB10201B |
Research Grade Prezalumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF68001A |
Research Grade Quetmolimab |
100 ug |
$380.00
|
|
BUY
|
| DHF68001B |
Research Grade Quetmolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD03702A |
Research Grade Rilotumumab |
100 ug |
$380.00
|
|
BUY
|
| DHD03702B |
Research Grade Rilotumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB10202B |
Research Grade Rozibafusp alfa |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHB10202A |
Research Grade Rozibafusp alfa |
100 ug |
$560.00
|
|
BUY
|
| DHD68903B |
Research Grade Selicrelumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD68903A |
Research Grade Selicrelumab |
100 ug |
$420.00
|
|
BUY
|
| DHB91701B |
Research Grade Tanezumab |
1.0 ug |
$1,520.00
|
|
BUY
|
| DHB91701A |
Research Grade Tanezumab |
100 ug |
$420.00
|
|
BUY
|
| DHD17204A |
Research Grade Ticilimumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17204B |
Research Grade Ticilimumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17203A |
Research Grade Tremelimumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17203B |
Research Grade Tremelimumab |
1.0 mg |
$1,380.00
|
|
BUY
|
